The WSJ today published yet ANOTHER article bashing biovail and OSTK, and arguing that short sellers are good for God and country.
These are getting a bit tedious in their sameness. They invariably make no distinctions between illegal stock manipulation and legal short selling, or illegal failure to deliver and legal short selling.
Almost all of them commence by framing the lawsuits against Gradient and SAC and Rocker Partners as an assault on short selling (legal) or the 1st Amendment rather than what they are - lawsuit alleging illegal front-running of bogus research reports, and stock manipulation.
Why all these smart NY press guys can't read a simple complaint and get it right is baffling.
They will then usually trumpet a study by an academic concluding that companies that fight short sellers are usually bad (again, forgetting that these companies aren't "fighting short sellers"), and finish with some sort of argument that shorts are good and honest and true, and that companies that take them on are bad bad bad. It is always the same paper by the same academic.
I don't have a lot of time to devote to debunking this article, so I'll just take a few snippets and indicate where the conspicuous flaws are. By now I can do this on auto-pilot. That is how similar all of them are.
"Who'd have guessed short selling would become a subject for the magazine shows, such as "60 Minutes" and "NBC Dateline"? Less surprising is that the take has been hostile and conspiratorial: How dare you push down stocks owned by widows, orphans and other helpless shareholders?
Case in point: a CBS piece two weeks ago that uncritically embraced a lawsuit against short sellers by Canadian drug maker Biovail. Led by CEO Edward Melnyk, the company charges that its share price has been driven down in the past three years by an unholy conspiracy of hedge funds and analysts who write unfavorable reports on the company. Not once but twice in her report CBS correspondent Lesley Stahl ominously intoned that hedge funds are both "secretive" and "virtually unregulated."
Here CBS News aligns itself with a campaign already promoted by eccentric Overstock.com CEO Patrick Byrne and billionaire anti-tobacco lawyer John O'Quinn, who was given airtime on NBC last year to claim that short selling abuse is rampant and costing American investors billions of dollars in stock value."
Yawn. So 60 Minutes is bad, and O'Quinn is bad. They mis-characterize O'Quinn's battle against stock manipulators who use failing to deliver as a strategy as "short selling abuse." They chastise 60 minutes for correctly pointing out that hedge funds are secretive (they are) and virtually unregulated (they are). So far so good, nothing surprising yet. Standard rhetorical slam using innuendo and misstatement as a substitute for reporting.
"Funny thing, the very same Messrs. Melnyk, Byrne and O'Quinn have been the subject of repeated roastings in the business press, including this newspaper, Fortune magazine and several other publications known for actually having a clue about the stock market. Indeed, much of the print press has come to the defense of the shorts: How dare you defame these investors who take special risks to make sure negative opinion is registered in the stock market? (Shorting is an onerous way to make money -- it involves borrowing stock and selling it, hoping to buy it back cheaper before the loan comes due.)
Not surprisingly, we put ourselves on the side of the shorts (and print media) too. But the debate has some interesting features that have been overlooked."
Not surprising at all, as the NEW YORK financial press is pretty much tied at the hip to Wall Street, and credulously parrots whatever is in Wall Street's best interests. Given that hedge funds make up most of the trading and stock lending business on the Street, it is absolutely unsurprising that the WSJ is pro-hedge fund/Wall Street agenda. And lets not forget that Dave Kansas is a Thestreet.com alumni - he's the C section editor, where much of this dross finds a home.
So again, to be clear - mis-characterize O'Quinn and Byrne's battle as against short sellers rather than against stock manipulators, and then cite a variation of "1 billion flies can't be wrong" argument in support of your erroneous straw man position.
"These swirling controversies have brought fame to a study by Yale's Owen Lamont. He looked at 266 companies that waged legal and political campaigns against short sellers and found that their returns lagged the market by 42% over the following three years. Proof, apparently, that short sellers are frequently right about the companies they target -- a view supported by a growing body of studies that find shorts are better informed than other investors.
But overlooked is another implication of Mr. Lamont's study: Returns were low precisely because the companies apparently stopped shorts from quickly knocking down their share prices to a level that would allow higher returns in the out years. Let's acknowledge, if so, that this represents a big favor to company insiders and savvy outside shareholders who were able to get out at a good price even after the shorts identified their companies as overvalued."
Here is the obligatory academic - again, ignoring that the suits are not about short selling, but rather about front-running doctored research reports - classic stock manipulation. Amazing how this escapes these guys.
And finally:
"In the Biovail matter, the agency seems to be myopically focused on the improbable premise that the market is being "manipulated" by impure research. To this end, it sent (and later recalled) subpoenas to journalists who reported negative views on Biovail and were presumably kept on speed dial by the shorts.
This maladroit intervention not only benefits those who'd like to make short selling as hard as possible. In keeping with the agency's chronic failure to catch up with the modern understanding of markets, the SEC's efforts once again have the effect of keeping good information out of stock prices, which only hurts all investors and the economy in the long run. Of course, if the SEC can't figure this out, why should anyone expect better of TV reporters?
Write to Holman W. Jenkins Jr. at holman.jenkins@wsj.com"
And finishing with the obligatory slam at the SEC for DARING to question the integrity of those honest journalists on Wall Street who just happen to constantly advance the agenda of those being accused of stock manipulation.
As I said, not much interesting. If I have the time I will create a template for one of these articles to save our find journalist friends the 45 seconds it takes to print the PR spin out and organize it as an article. Then again, I may have a mojito and lay in the sun instead. Hard to decide which would be more productive at this point...